User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

The impact of type 2 diabetes on bone fracture healing

  • Open access
  • PDF
  • 1.28 M
  1. Andrikopoulos Sofianos, Blair Amy R., Deluca Nadia, Fam Barbara C., Proietto Joseph, Evaluating the glucose tolerance test in mice, 10.1152/ajpendo.90617.2008
  2. Lecka-Czernik B., Stechschulte L.A., Czernik P.J., Dowling A.R., High bone mass in adult mice with diet-induced obesity results from a combination of initial increase in bone mass followed by attenuation in bone formation; implications for high bone mass and decreased bone quality in obesity, 10.1016/j.mce.2015.01.001
  3. Shu Lei, Beier Eric, Sheu Tzong, Zhang Hengwei, Zuscik Michael J., Puzas Edward J., Boyce Brendan F., Mooney Robert A., Xing Lianping, High-Fat Diet Causes Bone Loss in Young Mice by Promoting Osteoclastogenesis Through Alteration of the Bone Marrow Environment, 10.1007/s00223-015-9954-z
  4. Stabley J. N., Prisby R. D., Behnke B. J., Delp M. D., Type 2 diabetes alters bone and marrow blood flow and vascular control mechanisms in the ZDF rat, 10.1530/joe-14-0514
  5. Brown Matthew L., Yukata Kiminori, Farnsworth Christopher W., Chen Ding-Geng, Awad Hani, Hilton Matthew J., O'Keefe Regis J., Xing Lianping, Mooney Robert A., Zuscik Michael J., Delayed Fracture Healing and Increased Callus Adiposity in a C57BL/6J Murine Model of Obesity-Associated Type 2 Diabetes Mellitus, 10.1371/journal.pone.0099656
  6. Wu, Eur Rev Med Pharmacol Sci, 21, 470 (2017)
  7. Pscherer, Acta Chir Orthop Traumatol Cech, 82, 268 (2015)
  8. Rőszer Tamás, Inflammation as death or life signal in diabetic fracture healing, 10.1007/s00011-010-0246-9
  9. Rőszer Tamás, Józsa Tamás, Kiss-Tóth Éva D., De Clerck Nora, Balogh Lajos, Leptin receptor deficient diabetic (db/db) mice are compromised in postnatal bone regeneration, 10.1007/s00441-013-1768-6
  10. Hamann Christine, Goettsch Claudia, Mettelsiefen Jan, Henkenjohann Veit, Rauner Martina, Hempel Ute, Bernhardt Ricardo, Fratzl-Zelman Nadja, Roschger Paul, Rammelt Stefan, Günther Klaus-Peter, Hofbauer Lorenz C., Delayed bone regeneration and low bone mass in a rat model of insulin-resistant type 2 diabetes mellitus is due to impaired osteoblast function, 10.1152/ajpendo.00378.2011
  11. Starup-Linde Jakob, Vestergaard Peter, Biochemical bone turnover markers in diabetes mellitus — A systematic review, 10.1016/j.bone.2015.02.019
  12. Furst Jessica R., Bandeira Leonardo C., Fan Wen-Wei, Agarwal Sanchita, Nishiyama Kyle K., McMahon Donald J., Dworakowski Elzbieta, Jiang Hongfeng, Silverberg Shonni J., Rubin Mishaela R., Advanced Glycation Endproducts and Bone Material Strength in Type 2 Diabetes, 10.1210/jc.2016-1437
  13. Phimphilai Mattabhorn, Pothacharoen Peraphan, Kongtawelert Prachya, Chattipakorn Nipon, Impaired osteogenic differentiation and enhanced cellular receptor of advanced glycation end products sensitivity in patients with type 2 diabetes, 10.1007/s00774-016-0800-9
  14. Saito Mitsuru, Kida Yoshikuni, Kato Soki, Marumo Keishi, Diabetes, Collagen, and Bone Quality, 10.1007/s11914-014-0202-7
  15. Wallner Christoph, Schira Jessica, Wagner Johannes Maximilian, Schulte Matthias, Fischer Sebastian, Hirsch Tobias, Richter Wiltrud, Abraham Stephanie, Kneser Ulrich, Lehnhardt Marcus, Behr Björn, Application of VEGFA and FGF-9 Enhances Angiogenesis, Osteogenesis and Bone Remodeling in Type 2 Diabetic Long Bone Regeneration, 10.1371/journal.pone.0118823
  16. Chen Qing-Quan, Wang Wan-Ming, Expression of FGF-2 and IGF-1 in diabetic rats with fracture, 10.1016/s1995-7645(13)60195-9
  17. Fontaine Javier La, Hunt Nathan A., Curry Stacey, Kearney Tyler, Jupiter Daniel, Shibuya Naohiro, Lavery Lawrence A., Fracture Healing and Biomarker Expression in a Diabetic Zucker Rat Model, 10.7547/0003-0538-104.5.428
  18. Hamann Christine, Picke Ann-Kristin, Campbell Graeme M., Balyura Mariya, Rauner Martina, Bernhardt Ricardo, Huber Gerd, Morlock Michael M., Günther Klaus-Peter, Bornstein Stefan R., Glüer Claus-C., Ludwig Barbara, Hofbauer Lorenz C., Effects of Parathyroid Hormone on Bone Mass, Bone Strength, and Bone Regeneration in Male Rats With Type 2 Diabetes Mellitus, 10.1210/en.2013-1960
  19. Jeyabalan J., Viollet B., Smitham P., Ellis S. A., Zaman G., Bardin C., Goodship A., Roux J. P., Pierre M., Chenu C., The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing, 10.1007/s00198-013-2371-0
  20. Liu Lichu, Aronson James, Lecka-Czernik Beata, Rosiglitazone disrupts endosteal bone formation during distraction osteogenesis by local adipocytic infiltration, 10.1016/j.bone.2012.09.038
  21. Waddington Rachel J., Alraies Amr, Colombo John S., Sloan Alastair J., Okazaki Joji, Moseley Ryan, Characterization of Oxidative Stress Status during Diabetic Bone Healing, 10.1159/000324251
  22. Xu, Zhong Nan Da Xue Xue Bao Yi Xue Ban, 34, 957 (2009)
  23. Hernigou Philippe, Guissou Isaac, Homma Yasuhiro, Poignard Alexandre, Chevallier Nathalie, Rouard Helene, Flouzat Lachaniette Charles Henri, Percutaneous injection of bone marrow mesenchymal stem cells for ankle non-unions decreases complications in patients with diabetes, 10.1007/s00264-015-2738-2
  24. Wukich Dane K., Mallory Brady R., Suder Natalie C., Rosario Bedda L., Tibiotalocalcaneal Arthrodesis Using Retrograde Intramedullary Nail Fixation: Comparison of Patients With and Without Diabetes Mellitus, 10.1053/j.jfas.2015.02.019
  25. Nozaka Koji, Shimada Yoichi, Kimura Yoshiaki, Yamada Shin, Kashiwagura Takeshi, Sakuraba Tsutomu, Wakabayashi Ikuko, Successful treatment of nonunion with an Ilizarov ring fixator after ankle fracture for Charcot arthropathy: a case report, 10.1186/1756-0500-7-503
  26. Ricci William M., Streubel Philipp N., Morshed Saam, Collinge Cory A., Nork Sean E., Gardner Michael J., Risk Factors for Failure of Locked Plate Fixation of Distal Femur Fractures : An Analysis of 335 Cases, 10.1097/bot.0b013e31829e6dd0
  27. Shibuya Naohiro, Humphers Jon M., Fluhman Benjamin L., Jupiter Daniel C., Factors Associated with Nonunion, Delayed Union, and Malunion in Foot and Ankle Surgery in Diabetic Patients, 10.1053/j.jfas.2012.11.012
  28. Kline Alex J., Gruen Gary S., Pape Hans C., Tarkin Ivan S., Irrgang James J., Wukich Dane K., Early Complications Following the Operative Treatment of Pilon Fractures with and without Diabetes, 10.3113/fai.2009.1042
  29. Bahney Chelsea S., Hu Diane P., Miclau Theodore, Marcucio Ralph S., The Multifaceted Role of the Vasculature in Endochondral Fracture Repair, 10.3389/fendo.2015.00004
  30. S. Hayes Jessica, M. Coleman Cynthia, Diabetic Bone Fracture Repair: A Progenitor Cell-Based Paradigm, 10.2174/1574888x10666150306160433
  31. Jiao Hongli, Xiao E., Graves Dana T., Diabetes and Its Effect on Bone and Fracture Healing, 10.1007/s11914-015-0286-8
  32. Dede Anastasia D., Tournis Symeon, Dontas Ismene, Trovas George, Type 2 diabetes mellitus and fracture risk, 10.1016/j.metabol.2014.09.002
  33. Fadini Gian Paolo, Ferraro Francesca, Quaini Federico, Asahara Takayuki, Madeddu Paolo, Concise Review: Diabetes, the Bone Marrow Niche, and Impaired Vascular Regeneration, 10.5966/sctm.2014-0052
  34. Razzouk, N Y State Dent J, 79, 27 (2013)
  35. Sathyendra Vikram, Darowish Michael, Basic Science of Bone Healing, 10.1016/j.hcl.2013.08.002
  36. Borrelli Joseph, Pape Chris, Hak David, Hsu Joseph, Lin Sheldon, Giannoudis Peter, Lane Joseph, Physiological Challenges of Bone Repair : , 10.1097/bot.0b013e318274da8b
  37. Claes Lutz, Recknagel Stefan, Ignatius Anita, Fracture healing under healthy and inflammatory conditions, 10.1038/nrrheum.2012.1
  38. Simpson C., Jayaramaraju D., Agraharam D., Gudipati S., Shanmuganathan R., Giannoudis P. V., The effects of diabetes medications on post-operative long bone fracture healing, 10.1007/s00590-015-1691-5
  39. Retzepi M., Donos N., The effect of diabetes mellitus on osseous healing : The effect of diabetes mellitus on osseous healing, 10.1111/j.1600-0501.2010.01923.x
  40. Saito M., Fujii K., Mori Y., Marumo K., Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats, 10.1007/s00198-006-0155-5
  41. McCarthy Antonio D, Etcheverry Susana B, Bruzzone Liliana, Lettieri Gabriela, Barrio Daniel A, Cortizo Ana M, 10.1186/1471-2121-2-16
  42. Turecek C., Fratzl-Zelman N., Rumpler M., Buchinger B., Spitzer S., Zoehrer R., Durchschlag E., Klaushofer K., Paschalis E. P., Varga F., Collagen Cross-Linking Influences Osteoblastic Differentiation, 10.1007/s00223-008-9136-3
  43. Marin, J Sci Rep (2017)
  44. Qian Chao, Zhu Chenyuan, Yu Weiqiang, Jiang Xinquan, Zhang Fuqiang, High-Fat Diet/Low-Dose Streptozotocin-Induced Type 2 Diabetes in Rats Impacts Osteogenesis and Wnt Signaling in Bone Marrow Stromal Cells, 10.1371/journal.pone.0136390
  45. Reyes-García Rebeca, Rozas-Moreno Pedro, López-Gallardo Gema, García-Martín Antonia, Varsavsky Mariela, Avilés-Perez Maria Dolores, Muñoz-Torres Manuel, Serum levels of bone resorption markers are decreased in patients with type 2 diabetes, 10.1007/s00592-011-0347-0
  46. Manavalan J. S., Cremers S., Dempster D. W., Zhou H., Dworakowski E., Kode A., Kousteni S., Rubin M. R., Circulating Osteogenic Precursor Cells in Type 2 Diabetes Mellitus, 10.1210/jc.2012-1546
  47. Farr Joshua N, Drake Matthew T, Amin Shreyasee, Melton L Joseph, McCready Louise K, Khosla Sundeep, In Vivo Assessment of Bone Quality in Postmenopausal Women With Type 2 Diabetes : BONE QUALITY IN WOMEN WITH T2D, 10.1002/jbmr.2106
  48. Gennari Luigi, Merlotti Daniela, Valenti Roberto, Ceccarelli Elena, Ruvio Martina, Pietrini Maria G., Capodarca Cosimo, Franci Maria Beatrice, Campagna Maria Stella, Calabrò Anna, Cataldo Dorica, Stolakis Konstantinos, Dotta Francesco, Nuti Ranuccio, Circulating Sclerostin Levels and Bone Turnover in Type 1 and Type 2 Diabetes, 10.1210/jc.2011-2958
  49. Sarkar Purnima Dey, Choudhury Anil Baran, Relationship of serum osteocalcin levels with blood glucose, insulin resistance and lipid profile in central Indian men with type 2 diabetes, 10.3109/13813455.2012.715651
  50. Kerckhofs G., Durand M., Vangoitsenhoven R., Marin C., Van der Schueren B., Carmeliet G., Luyten F. P., Geris L., Vandamme K., Changes in bone macro- and microstructure in diabetic obese mice revealed by high resolution microfocus X-ray computed tomography, 10.1038/srep35517
  51. Sosa Manuel, Dominguez Miri, Navarro Mary C., Segarra Mary C., Hernández D., de Pablos P., Betancor Pedro, Bone mineral metabolism is normal in non-insulin-dependent diabetes mellitus, 10.1016/1056-8727(95)00062-3
  52. Hamilton Emma J., Rakic Valentina, Davis Wendy A., Paul Chubb S. A., Kamber Niklaus, Prince Richard L., Davis Timothy M. E., A five-year prospective study of bone mineral density in men and women with diabetes: The Fremantle Diabetes Study, 10.1007/s00592-011-0324-7
  53. van Lierop A. H., Hamdy N. A. T., van der Meer R. W., Jonker J. T., Lamb H. J., Rijzewijk L. J., Diamant M., Romijn J. A., Smit J. W. A., Papapoulos S. E., Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus, 10.1530/eje-11-1061
  54. Ortinau Laura C., Linden Melissa A., Dirkes Rebecca, Rector R. Scott, Hinton Pamela S., Obesity and type 2 diabetes, not a diet high in fat, sucrose, and cholesterol, negatively impacts bone outcomes in the hyperphagic Otsuka Long Evans Tokushima Fatty rat, 10.1016/j.bone.2017.09.003
  55. Nuche-Berenguer Bernardo, Moreno Paola, Esbrit Pedro, Dapía Sonia, Caeiro José R., Cancelas Jesús, Haro-Mora Juan J., Villanueva-Peñacarrillo María L., Effect of GLP-1 Treatment on Bone Turnover in Normal, Type 2 Diabetic, and Insulin-Resistant States, 10.1007/s00223-009-9220-3
  56. Halade Ganesh V., Rahman Md M., Williams Paul J., Fernandes Gabriel, High fat diet-induced animal model of age-associated obesity and osteoporosis, 10.1016/j.jnutbio.2009.10.002
  57. Patsch Janina M., Kiefer Florian W., Varga Peter, Pail Pamela, Rauner Martina, Stupphann Daniela, Resch Heinrich, Moser Doris, Zysset Philippe K., Stulnig Thomas M., Pietschmann Peter, Increased bone resorption and impaired bone microarchitecture in short-term and extended high-fat diet–induced obesity, 10.1016/j.metabol.2009.11.023
  58. Eriksen, J Bone Miner Res, 17, N95 (2002)
  59. Jiang Jin, Lichtler Alexander C., Gronowicz Gloria A., Adams Douglas J., Clark Stephen H., Rosen Clifford J., Kream Barbara E., Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling, 10.1016/j.bone.2006.02.068
  60. Stegen Steve, van Gastel Nick, Carmeliet Geert, Bringing new life to damaged bone: The importance of angiogenesis in bone repair and regeneration, 10.1016/j.bone.2014.09.017
  61. Hu Kai, Olsen Bjorn R., Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair, 10.1172/jci82585
  62. Schmidt-Bleek Katharina, Schell Hanna, Lienau Jasmin, Schulz Norma, Hoff Paula, Pfaff Michael, Schmidt Gregor, Martin Claudia, Perka Carsten, Buttgereit Frank, Volk Hans-Dieter, Duda Georg, Initial immune reaction and angiogenesis in bone healing : Initial immune reaction and angiogenesis in bone healing, 10.1002/term.1505
  63. Lu Chuanyong, Miclau Theodore, Hu Diane, Marcucio Ralph S., Ischemia leads to delayed union during fracture healing: A mouse model, 10.1002/jor.20264
  64. Jack Megan, Wright Douglas, Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy, 10.1016/j.trsl.2011.12.004
  65. Yan Xiaoxiang, Sano Motoaki, Lu Lin, Wang Wei, Zhang Qi, Zhang Ruiyan, Wang Lingjie, Chen Qiujing, Fukuda Keiichi, Shen Weifeng, Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus, 10.1186/1475-2840-9-70
  66. Payne John, Ray Robin, Watson David, Delille Cecile, Rimler Eva, Cleveland Julia, Lynn Michael, Tangpricha Vin, Srivastava Sunil, Vitamin D Insufficiency in Diabetic Retinopathy, 10.4158/ep11147.or
  67. Thompson, Changes, 29, 997 (2012)
  68. Waltenberger J, Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications, 10.1016/s0008-6363(00)00228-5
  69. Orimo Hideo, Shimada Takashi, The role of tissue-nonspecific alkaline phosphatase in the phosphate-induced activation of alkaline phosphatase and mineralization in SaOS-2 human osteoblast-like cells, 10.1007/s11010-008-9788-3
  70. Pai Ashwini, Leaf Elizabeth M., El-Abbadi Mohga, Giachelli Cecilia M., Elastin Degradation and Vascular Smooth Muscle Cell Phenotype Change Precede Cell Loss and Arterial Medial Calcification in a Uremic Mouse Model of Chronic Kidney Disease, 10.1016/j.ajpath.2010.10.006
  71. Cheng S.-L., Behrmann A., Shao J.-S., Ramachandran B., Krchma K., Bello Arredondo Y., Kovacs A., Mead M., Maxson R., Towler D. A., Targeted Reduction of Vascular Msx1 and Msx2 Mitigates Arteriosclerotic Calcification and Aortic Stiffness in LDLR-Deficient Mice Fed Diabetogenic Diets, 10.2337/db14-0326
  72. Koike Sayo, Yano Shozo, Tanaka Sayuri, Sheikh Abdullah, Nagai Atsushi, Sugimoto Toshitsugu, Advanced Glycation End-Products Induce Apoptosis of Vascular Smooth Muscle Cells: A Mechanism for Vascular Calcification, 10.3390/ijms17091567
  73. Wang Zhongqun, Li Lihua, Du Rui, Yan Jinchuan, Liu Naifeng, Yuan Wei, Jiang Yicheng, Xu Suining, Ye Fei, Yuan Guoyue, Zhang Baohai, Liu Peijing, CML/RAGE signal induces calcification cascade in diabetes, 10.1186/s13098-016-0196-7
  74. Lombardo Marco F., Iacopino Pasquale, Cuzzola Maria, Spiniello Elisa, Garreffa Cristina, Ferrelli Francesca, Coppola Andrea, Saccardi Riccardo, Piaggesi Alberto, Piro Rosanna, Mannino Domenico, Grossi Giovanni, Lauro Davide, Irrera Giuseppe, Type 2 diabetes mellitus impairs the maturation of endothelial progenitor cells and increases the number of circulating endothelial cells in peripheral blood, 10.1002/cyto.a.22109
  75. Claes, J Orthop Res, 24, 1178 (2006)
  76. Raggatt Liza J., Wullschleger Martin E., Alexander Kylie A., Wu Andy C.K., Millard Susan M., Kaur Simranpreet, Maugham Michelle L., Gregory Laura S., Steck Roland, Pettit Allison R., Fracture Healing via Periosteal Callus Formation Requires Macrophages for Both Initiation and Progression of Early Endochondral Ossification, 10.1016/j.ajpath.2014.08.017
  77. Phillips A.M., Overview of the fracture healing cascade, 10.1016/j.injury.2005.07.027
  78. McCullen Seth D, Chow Andre GY, Stevens Molly M, In vivo tissue engineering of musculoskeletal tissues, 10.1016/j.copbio.2011.05.001
  79. Roy Bipradas, Biomolecular basis of the role of diabetes mellitus in osteoporosis and bone fractures, 10.4239/wjd.v4.i4.101
  80. Bakker Astrid D., Schrooten Jan, van Cleynenbreugel Tim, Vanlauwe Johan, Luyten Jan, Schepers Evert, Dubruel Peter, Schacht Etienne, Lammens Johan, Luyten Frank P., Quantitative Screening of Engineered Implants in a Long Bone Defect Model in Rabbits, 10.1089/ten.tec.2008.0022
  81. Fujii Hideki, Hamada Yasuhiro, Fukagawa Masafumi, Bone formation in spontaneously diabetic Torii-newly established model of non-obese type 2 diabetes rats, 10.1016/j.bone.2007.10.007
  82. Wittrant Y., Gorin Y., Woodruff K., Horn D., Abboud H.E., Mohan S., Abboud-Werner S.L., High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis, 10.1016/j.bone.2008.02.006
  83. Kawashima Yuki, Fritton J. Christopher, Yakar Shoshana, Epstein Sol, Schaffler Mitchell B., Jepsen Karl J., LeRoith Derek, Type 2 diabetic mice demonstrate slender long bones with increased fragility secondary to increased osteoclastogenesis, 10.1016/j.bone.2008.12.012
  84. Kayal Rayyan A, Siqueira Michelle, Alblowi Jazia, McLean Jody, Krothapalli Nanarao, Faibish Dan, Einhorn Thomas A, Gerstenfeld Louis C, Graves Dana T, TNF-α mediates diabetes-enhanced chondrocyte apoptosis during fracture healing and stimulates chondrocyte apoptosis Through FOXO1, 10.1002/jbmr.59
  85. Lim Jason C., Ko Kang I., Mattos Marcelo, Fang Miao, Zhang Citong, Feinberg Daniel, Sindi Hisham, Li Shuai, Alblowi Jazia, Kayal Rayyan A., Einhorn Thomas A., Gerstenfeld Louis C., Graves Dana T., TNFα contributes to diabetes impaired angiogenesis in fracture healing, 10.1016/j.bone.2017.02.014
  86. Halade Ganesh V., El Jamali Amina, Williams Paul J., Fajardo Roberto J., Fernandes Gabriel, Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice, 10.1016/j.exger.2010.09.014
  87. Gehling Daniel J., Lecka-Czernik Beata, Ebraheim Nabil A., Orthopedic complications in diabetes, 10.1016/j.bone.2015.07.029
  88. Ganesh Shanti P., The Impact of Diabetes on Patient Outcomes After Ankle Fracture, 10.2106/jbjs.d.02625
  89. Egol Kenneth A., Tejwani Nirmal C., Walsh Michael G., Capla Edward L., Koval Kenneth J., Predictors of Short-Term Functional Outcome Following Ankle Fracture Surgery : , 10.2106/jbjs.e.00343
  90. Low, Ann Acad Med Singapore, 24, 353 (1995)
  91. SooHoo Nelson F, Krenek Lucie, Eagan Michael J, Gurbani Barkha, Ko Clifford Y, Zingmond David S, Complication Rates Following Open Reduction and Internal Fixation of Ankle Fractures : , 10.2106/jbjs.h.00653
  92. Blotter Robert H., Connolly Edward, Wasan Ajay, Chapman Michael W., Acute Complications in the Operative Treatment of Isolated Ankle Fractures in Patients with Diabetes Mellitus, 10.1177/107110079902001103
  93. White Christopher B., Turner Norman S., Lee Gwo-Chin, Haidukewych George J., Open Ankle Fractures in Patients With Diabetes Mellitus : , 10.1097/01.blo.0000084402.53464.90
  94. Melton III L. J., Crowson C. S., O'Fallon W. M., Fracture Incidence in Olmsted County, Minnesota: Comparison of Urban with Rural Rates and Changes in Urban Rates Over time, 10.1007/s001980050113
  95. Abrahamsen B., Vestergaard P., Declining incidence of hip fractures and the extent of use of anti-osteoporotic therapy in Denmark 1997–2006, 10.1007/s00198-009-0957-3
  96. White S.M., Griffiths R., Projected incidence of proximal femoral fracture in England: A report from the NHS Hip Fracture Anaesthesia Network (HIPFAN), 10.1016/j.injury.2010.11.010
  97. Vestergaard P., Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis, 10.1007/s00198-006-0253-4
  98. Clarke B.L., Association of BMD and FRAX Score With Risk of Fracture in Older Adults With Type 2 Diabetes, 10.1016/j.yend.2012.03.048
  99. Oei L., Zillikens M. C., Dehghan A., Buitendijk G. H. S., Castano-Betancourt M. C., Estrada K., Stolk L., Oei E. H. G., van Meurs J. B. J., Janssen J. A. M. J. L., Hofman A., van Leeuwen J. P. T. M., Witteman J. C. M., Pols H. A. P., Uitterlinden A. G., Klaver C. C. W., Franco O. H., Rivadeneira F., High Bone Mineral Density and Fracture Risk in Type 2 Diabetes as Skeletal Complications of Inadequate Glucose Control: The Rotterdam Study, 10.2337/dc12-1188
  100. Vestergaard P., Rejnmark L., Mosekilde L., Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk, 10.1007/s00125-005-1786-3
  101. Hamann Christine, Rauner Martina, Höhna Yvonne, Bernhardt Ricardo, Mettelsiefen Jan, Goettsch Claudia, Günther Klaus-Peter, Stolina Marina, Han Chun-Ya, Asuncion Franklin J, Ominsky Michael S, Hofbauer Lorenz C, Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus, 10.1002/jbmr.1803
  102. Reyes C., Estrada P., Nogués X., Orozco P., Cooper C., Díez-Pérez A., Formiga F., Mácias J. G., Prieto-Alhambra D., The impact of common co-morbidities (as measured using the Charlson index) on hip fracture risk in elderly men: a population-based cohort study, 10.1007/s00198-014-2682-9
  103. Belmont Philip J., Garcia E’Stephan J., Romano David, Bader Julia O., Nelson Kenneth J., Schoenfeld Andrew J., Risk factors for complications and in-hospital mortality following hip fractures: a study using the National Trauma Data Bank, 10.1007/s00402-014-1959-y
  104. Norris Rory, Parker Martyn, Diabetes mellitus and hip fracture: A study of 5966 cases, 10.1016/j.injury.2011.03.021
  105. Meier Christian, Schwartz Ann V., Egger Andrea, Lecka-Czernik Beata, Effects of diabetes drugs on the skeleton, 10.1016/j.bone.2015.04.026
  106. Zinman Bernard, Haffner Steven M., Herman William H., Holman Rury R., Lachin John M., Kravitz Barbara G., Paul Gitanjali, Jones Nigel P., Aftring R. Paul, Viberti Giancarlo, Kahn Steven E., Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes, 10.1210/jc.2009-0572
  107. Colhoun H. M., , Livingstone S. J., Looker H. C., Morris A. D., Wild S. H., Lindsay R. S., Reed C., Donnan P. T., Guthrie B., Leese G. P., McKnight J., Pearson D. W. M., Pearson E., Petrie J. R., Philip S., Sattar N., Sullivan F. M., McKeigue P., Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs, 10.1007/s00125-012-2668-0
  108. Kahn Steven E., Haffner Steven M., Heise Mark A., Herman William H., Holman Rury R., Jones Nigel P., Kravitz Barbara G., Lachin John M., O'Neill M. Colleen, Zinman Bernard, Viberti Giancarlo, Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy, 10.1056/nejmoa066224
  109. Kahn S. E., Zinman B., Lachin J. M., Haffner S. M., Herman W. H., Holman R. R., Kravitz B. G., Yu D., Heise M. A., Aftring R. P., Viberti G., , Rosiglitazone-Associated Fractures in Type 2 Diabetes: An analysis from A Diabetes Outcome Progression Trial (ADOPT), 10.2337/dc07-2270
  110. Lazarenko Oxana P., Rzonca Sylwia O., Hogue William R., Swain Frances L., Suva Larry J., Lecka-Czernik Beata, Rosiglitazone Induces Decreases in Bone Mass and Strength that Are Reminiscent of Aged Bone, 10.1210/en.2006-1587
  111. Beck George R., Khazai Natasha B., Bouloux Gary F., Camalier Corinne E., Lin Yiming, Garneys Laura M., Siqueira Joselita, Peng Limin, Pasquel Francisco, Umpierrez Denise, Smiley Dawn, Umpierrez Guillermo E., The effects of thiazolidinediones on human bone marrow stromal cell differentiation in vitro and in thiazolidinedione-treated patients with type 2 diabetes, 10.1016/j.trsl.2012.08.006
  112. Jang Won Gu, Kim Eun Jung, Bae In-Ho, Lee Kkot-Nim, Kim Yong Deuk, Kim Don-Kyu, Kim Sun-Hun, Lee Chul-Ho, Franceschi Renny T, Choi Hueng-Sik, Koh Jeong-Tae, Metformin induces osteoblast differentiation via orphan nuclear receptor SHP-mediated transactivation of Runx2, 10.1016/j.bone.2010.12.003
  113. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study, 10.1016/s2213-8587(15)00291-0
  114. Ma Xue, Meng Jingru, Jia Min, Bi Long, Zhou Ying, Wang Yukun, Hu Jing, He Gonghao, Luo Xiaoxing, Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Prevents Osteopenia by Promoting Bone Formation and Suppressing Bone Resorption in Aged Ovariectomized Rats : EXENDIN-4 PREVENTS OSTEOPENIA IN AGED OVARIECTOMIZED RATS, 10.1002/jbmr.1898
  115. Pereira M., Jeyabalan J., Jørgensen C.S., Hopkinson M., Al-Jazzar A., Roux J.P., Chavassieux P., Orriss I.R., Cleasby M.E., Chenu C., Chronic administration of Glucagon-like peptide-1 receptor agonists improves trabecular bone mass and architecture in ovariectomised mice, 10.1016/j.bone.2015.08.006
  116. Kim Ju-Young, Lee Seong-Kyu, Jo Kyung-Jin, Song Dae-Yong, Lim Dong-Mee, Park Keun-Young, Bonewald Lynda F., Kim Byung-Joon, Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes, 10.1016/j.lfs.2013.01.001
  117. Ljunggren Ö., Bolinder J., Johansson L., Wilding J., Langkilde A. M., Sjöström C. D., Sugg J., Parikh S., Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin, 10.1111/j.1463-1326.2012.01630.x
  118. Yokono Masanori, Takasu Toshiyuki, Hayashizaki Yuka, Mitsuoka Keisuke, Kihara Rumi, Muramatsu Yuko, Miyoshi Sousuke, Tahara Atsuo, Kurosaki Eiji, Li Qun, Tomiyama Hiroshi, Sasamata Masao, Shibasaki Masayuki, Uchiyama Yasuo, SGLT2 selective inhibitor ipragliflozin reduces body fat mass by increasing fatty acid oxidation in high-fat diet-induced obese rats, 10.1016/j.ejphar.2014.01.040
  119. Kohan Donald E., Fioretto Paola, Tang Weihua, List James F., Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control, 10.1038/ki.2013.356
  120. Bilezikian John P., Watts Nelson B., Usiskin Keith, Polidori David, Fung Albert, Sullivan Daniel, Rosenthal Norm, Evaluation of Bone Mineral Density and Bone Biomarkers in Patients With Type 2 Diabetes Treated With Canagliflozin, 10.1210/jc.2015-1860
  121. List J. F., Woo V., Morales E., Tang W., Fiedorek F. T., Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes, 10.2337/dc08-1863
  122. Weir Matthew R., Kline Irina, Xie John, Edwards Robert, Usiskin Keith, Effect of canagliflozin on serum electrolytes in patients with type 2 diabetes in relation to estimated glomerular filtration rate (eGFR), 10.1185/03007995.2014.919907
  123. Quarles L. Darryl, Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism, 10.1038/nrendo.2011.218
  124. Palermo A., D’Onofrio L., Eastell R., Schwartz A. V., Pozzilli P., Napoli N., Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review, 10.1007/s00198-015-3123-0
  125. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F.C, Krause D.S., Deans R.J., Keating A., Prockop D.J., Horwitz E.M., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, 10.1080/14653240600855905
  126. Matsushima Seika, Isogai Noritaka, Jacquet Robin, Lowder Elizabeth, Tokui Taku, Landis William J., The Nature and Role of Periosteum in Bone and Cartilage Regeneration, 10.1159/000324642
  127. Liu Yi, Wang Lei, Kikuiri Takashi, Akiyama Kentaro, Chen Chider, Xu Xingtian, Yang Ruili, Chen WanJun, Wang Songlin, Shi Songtao, Mesenchymal stem cell–based tissue regeneration is governed by recipient T lymphocytes via IFN-γ and TNF-α, 10.1038/nm.2542
  128. Murao Hiroki, Yamamoto Koji, Matsuda Shuichi, Akiyama Haruhiko, Periosteal cells are a major source of soft callus in bone fracture, 10.1007/s00774-013-0429-x
  129. Bolander Johanna, Chai Yoke Chin, Geris Liesbet, Schrooten Jan, Lambrechts Dennis, Roberts Scott J., Luyten Frank P., Early BMP, Wnt and Ca2+/PKC pathway activation predicts the bone forming capacity of periosteal cells in combination with calcium phosphates, 10.1016/j.biomaterials.2016.01.059
  130. Tevlin Ruth, Seo Eun Young, Marecic Owen, McArdle Adrian, Tong Xinming, Zimdahl Bryan, Malkovskiy Andrey, Sinha Rahul, Gulati Gunsagar, Li Xiyan, Wearda Taylor, Morganti Rachel, Lopez Michael, Ransom Ryan C., Duldulao Christopher R., Rodrigues Melanie, Nguyen Allison, Januszyk Michael, Maan Zeshaan, Paik Kevin, Yapa Kshemendra-Senarath, Rajadas Jayakumar, Wan Derrick C., Gurtner Geoffrey C., Snyder Michael, Beachy Philip A., Yang Fan, Goodman Stuart B., Weissman Irving L., Chan Charles K. F., Longaker Michael T., Pharmacological rescue of diabetic skeletal stem cell niches, 10.1126/scitranslmed.aag2809
  131. Wang J.-M., Tao J., Chen D.-D., Cai J.-J., Irani K., Wang Q., Yuan H., Chen A. F., MicroRNA miR-27b Rescues Bone Marrow-Derived Angiogenic Cell Function and Accelerates Wound Healing in Type 2 Diabetes Mellitus, 10.1161/atvbaha.113.302104
  132. Bae O.-N., Wang J.-M., Baek S.-H., Wang Q., Yuan H., Chen A. F., Oxidative Stress-Mediated Thrombospondin-2 Upregulation Impairs Bone Marrow-Derived Angiogenic Cell Function in Diabetes Mellitus, 10.1161/atvbaha.113.301609
Bibliographic reference Marin, Carlos ; Luyten, Frank ; Van Der Schueren, Bart ; Kerckhofs, Greet ; Vandamme, Katleen. The impact of type 2 diabetes on bone fracture healing. In: Frontiers in Endocrinology, Vol. 9, no. 6 (2018)
Permanent URL http://hdl.handle.net/2078/194643